SC 13G/A | 2023-02-13 | Capital International Investors | HUTCHMED (China) Ltd | 13,102,356 | 1.5% | EDGAR |
SC 13G/A | 2022-02-11 | Capital International Investors | HUTCHMED (China) Ltd | 80,310,930 | 9.3% | EDGAR |
SC 13D/A | 2022-02-07 | HUTCHMED (China) Ltd | Epizyme, Inc. | 5,653,000 | 3.4% | EDGAR |
SC 13D | 2021-08-16 | HUTCHMED (China) Ltd | Epizyme, Inc. | 5,653,000 | 5.2% | EDGAR |
SC 13D/A | 2021-07-01 | GENERAL ATLANTIC LLC | HUTCHMED (China) Ltd | 42,501,670 | 4.9% | EDGAR |
SC 13D/A | 2021-06-30 | CK Hutchison Holdings Ltd | HUTCHMED (China) Ltd | 332,478,770 | 39.2% | EDGAR |
SC 13D/A | 2021-04-13 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 332,478,770 | 44.7% | EDGAR |
SC 13G/A | 2021-02-16 | Capital International Investors | Hutchison China MediTech Ltd | 52,958,742 | 7.3% | EDGAR |
SC 13D/A | 2020-11-27 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 332,478,770 | 45.7% | EDGAR |
SC 13D/A | 2020-07-07 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 332,478,770 | 46.8% | EDGAR |
SC 13D | 2020-07-06 | GENERAL ATLANTIC LLC | Hutchison China MediTech Ltd | 36,666,670 | 5.0% | EDGAR |
SC 13G | 2020-02-14 | Capital International Investors | Hutchison China MediTech Ltd | 42,159,985 | 6.3% | EDGAR |
SC 13D/A | 2020-01-29 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 332,478,770 | 48.3% | EDGAR |
SC 13D/A | 2019-09-30 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 332,478,770 | 49.9% | EDGAR |
SC 13D/A | 2019-07-02 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 340,978,770 | 51.2% | EDGAR |
SC 13G/A | 2018-02-13 | MITSUI & CO LTD | Hutchison China MediTech Ltd | 3,214,404 | 4.8% | EDGAR |
SC 13D | 2017-11-09 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 40,097,877 | 60.4% | EDGAR |
SC 13G | 2017-02-13 | MITSUI & CO LTD | Hutchison China MediTech Ltd | 3,214,404 | 5.3% | EDGAR |
SC 13G | 2017-02-08 | CK Hutchison Holdings Ltd | Hutchison China MediTech Ltd | 36,666,667 | 60.4% | EDGAR |